US 11851655
Compositions and methods for modulating apolipoprotein (a) expression
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 11851655 (Compositions and methods for modulating apolipoprotein (a) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/549, A61K47/59